PHARMIX CORP has a total of 20 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets computer technology, pharmaceuticals and organic fine chemistry are SINOVEDA CANADA INC, LUNELLA BIOTECH INC and BIOINFORMATICS & MOLECULAR DESIGN RES CT.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Yu Jessen | 13 |
#2 | Mydlowec William | 8 |
#3 | Lanza Guido | 8 |
#4 | Griffin John | 6 |
#5 | Bennett Forrest H Iii | 5 |
#6 | Mydlowec William J | 3 |
#7 | Duffy Nigel P | 3 |
#8 | Bennett Iii Forrest H | 2 |
#9 | William Mydlowec | 1 |
#10 | John Griffin | 1 |
Publication | Filing date | Title |
---|---|---|
US2005277653A1 | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | |
CN101426503A | Compositions and treatments for inhibiting kinase and/or HMG-COA reductase | |
US2005261354A1 | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | |
US2005288306A1 | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | |
AU2003303152A1 | Method and apparatus for quantum mechanical analysis of molecular systems | |
US2003220716A1 | Method and apparatus for automated design of chemical synthesis routes | |
US6571226B1 | Method and apparatus for automated design of chemical synthesis routes |